<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02530541</url>
  </required_header>
  <id_info>
    <org_study_id>R14-015</org_study_id>
    <nct_id>NCT02530541</nct_id>
  </id_info>
  <brief_title>Antimicrobial Efficacy of 2% CHG (Chlorhexidine Gluconate)</brief_title>
  <official_title>Pilot Trial Assessment of the Antimicrobial Efficacy of Medline 2% CHG Cloth Preoperative Skin Preparation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medline Industries</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medline Industries</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pilot study to evaluate and compare activity of preoperative preparation with comparator&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluate and compare similar preoperative surgical preparations in healthy volunteers.&#xD;
      Various application times were evaluated. Efficacy was assess using TFM criteria.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Log Reduction of Bacterial Flora on the Abdomen and Groin</measure>
    <time_frame>10 min, 6 hr and 8 hr</time_frame>
    <description>Evaluate the Log Reduction of normal flora at various timepoints.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>CHG 1 min</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 min application time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHG 2 min</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 min application time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator CHG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Marketed CHG</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>CHG</intervention_name>
    <description>Varied application times</description>
    <arm_group_label>CHG 1 min</arm_group_label>
    <arm_group_label>CHG 2 min</arm_group_label>
    <arm_group_label>Comparator CHG</arm_group_label>
    <other_name>Chlorhexidine Gluconate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy&#xD;
&#xD;
          -  No dermatological conditions&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Sensitivity to CHG&#xD;
&#xD;
          -  Sensitivity to natural latex rubber or adhesive skin products&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Esther Campbell</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bioscience Labs</affiliation>
  </overall_official>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 16, 2015</study_first_submitted>
  <study_first_submitted_qc>August 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2015</study_first_posted>
  <results_first_submitted>November 25, 2015</results_first_submitted>
  <results_first_submitted_qc>April 29, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">April 30, 2021</results_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data to be shared with FDA</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Upon achieving sufficient microbial growth prior to product application on either the abdomen, groin or both abdomen and groin regions, sites of the participant were then randomized to receive one or two products for evaluation for up to 4 sites. Differences in the number of participants is based on microbial qualifications.</recruitment_details>
      <pre_assignment_details>Participants were randomized to be treated with at least 2 treatments/ Arms (out of 3) at the same time for both groin and abdomen. Total numbers represent sites not the individual number of participants.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>CHG 1 Min Abdomen</title>
          <description>CHG 1 min Abdomen sites</description>
        </group>
        <group group_id="P2">
          <title>CHG 2 Min Abdomen</title>
          <description>CHG 2 min Abdomen sites</description>
        </group>
        <group group_id="P3">
          <title>Comparator CHG Abdomen</title>
          <description>Marketed CHG - only applied per products instructions for use</description>
        </group>
        <group group_id="P4">
          <title>CHG 1 Min Groin</title>
          <description>CHG 1 min Groin sites</description>
        </group>
        <group group_id="P5">
          <title>CHG 2 Min Groin</title>
          <description>CHG 2 min Groin sites</description>
        </group>
        <group group_id="P6">
          <title>Comparator CHG Groin</title>
          <description>Marketed CHG - only applied per products instructions for use</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="23"/>
                <participants group_id="P3" count="22"/>
                <participants group_id="P4" count="21"/>
                <participants group_id="P5" count="20"/>
                <participants group_id="P6" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="14"/>
                <participants group_id="P4" count="15"/>
                <participants group_id="P5" count="15"/>
                <participants group_id="P6" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="6"/>
                <participants group_id="P5" count="5"/>
                <participants group_id="P6" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participants received up to 2 treatments at the same time. The treatments included 2 different testing sites.</population>
      <group_list>
        <group group_id="B1">
          <title>CHG 1, CHG 2, Comparator CHG</title>
          <description>Participants could receive up to 2 different treatments at the same time. Treatments included CHG at 1 min, CHG at 2 min or Comparator CHG.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="33"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <title>Age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48" lower_limit="19" upper_limit="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <description>33 participants were evaluated with up to 2 products. However only participants that achieved baseline criteria based on post testing analysis were used in the final analysis. The total of participants used was 21.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Sites exposed</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Log Reduction of Bacterial Flora on the Abdomen and Groin</title>
        <description>Evaluate the Log Reduction of normal flora at various timepoints.</description>
        <time_frame>10 min, 6 hr and 8 hr</time_frame>
        <population>Determine 70% responder rates</population>
        <group_list>
          <group group_id="O1">
            <title>CHG 1 Min Abdomen</title>
            <description>1 min application time</description>
          </group>
          <group group_id="O2">
            <title>CHG 2 Min Abdomen</title>
            <description>2 min application time</description>
          </group>
          <group group_id="O3">
            <title>Comparator CHG Abdomen</title>
            <description>Marketed CHG Standard Application Time</description>
          </group>
          <group group_id="O4">
            <title>CHG 1 Min Groin</title>
            <description>1 min application time</description>
          </group>
          <group group_id="O5">
            <title>CHG 2 Min Groin</title>
            <description>2 min application time</description>
          </group>
          <group group_id="O6">
            <title>Comparator CHG Groin</title>
            <description>Comparator CHG Standard Application Time</description>
          </group>
        </group_list>
        <measure>
          <title>Log Reduction of Bacterial Flora on the Abdomen and Groin</title>
          <description>Evaluate the Log Reduction of normal flora at various timepoints.</description>
          <population>Determine 70% responder rates</population>
          <units>Log10 Reductions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Sites Exposed</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="21"/>
                <count group_id="O5" value="20"/>
                <count group_id="O6" value="19"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Sites Exposed</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="21"/>
                <count group_id="O5" value="20"/>
                <count group_id="O6" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>10 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="1.6"/>
                    <measurement group_id="O2" value="2.0" spread="1.5"/>
                    <measurement group_id="O3" value="1.3" spread="1.8"/>
                    <measurement group_id="O4" value="1.9" spread="0.6"/>
                    <measurement group_id="O5" value="2.4" spread="1.1"/>
                    <measurement group_id="O6" value="2.1" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" spread="1.3"/>
                    <measurement group_id="O2" value="2.5" spread="1.4"/>
                    <measurement group_id="O3" value="1.7" spread="1.6"/>
                    <measurement group_id="O4" value="2.3" spread="0.8"/>
                    <measurement group_id="O5" value="2.8" spread="1.2"/>
                    <measurement group_id="O6" value="1.9" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" spread="1.0"/>
                    <measurement group_id="O2" value="2.2" spread="1.6"/>
                    <measurement group_id="O3" value="1.4" spread="1.2"/>
                    <measurement group_id="O4" value="2.5" spread="0.9"/>
                    <measurement group_id="O5" value="2.7" spread="0.8"/>
                    <measurement group_id="O6" value="2.2" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were monitored from baseline out to 8 hours.</time_frame>
      <desc>Participants received up to 2 products at the same time.</desc>
      <group_list>
        <group group_id="E1">
          <title>CHG 1 Min, CHG 2 Min, Comparator CHG</title>
          <description>1 min application time, 2 min application time or comparator application. Up to 2 products applied to the same participant.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Data considered confidential</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Small sample size.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>C. Beausoleil</name_or_title>
      <organization>BSL</organization>
      <phone>406-587-5735</phone>
      <email>cbeausoleil@biosciencelabs.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

